Specialty × MAC Jurisdiction Intelligence
RheumatologyCMS & MAC AlertsNovitas Solutions · Jurisdictions JH, JL
Every CMS transmittal, Novitas Solutions LCD revision, Federal Register notice, and OIG alert affecting Rheumatology billing teams in Arkansas, Colorado, Louisiana, Mississippi, New Mexico, Oklahoma, Texas, Delaware, District of Columbia, Maryland, New Jersey, Pennsylvania. Signal-scored and updated daily.
Active alerts
11
Critical / High
4
MAC jurisdiction
JH, JL
Highest-risk CPT
CPT 99214
Recent Rheumatology alerts under Novitas Solutions
4 of the 11 most recent Rheumatology reimbursement alerts are Critical/High-severity for Novitas Solutions (Jurisdictions JH, JL) billing teams. Each links to the source CMS/MAC document with the codes to review and the action to take.
- FDA Approval: XELJANZ (TOFACITINIB) — Type 1 - New Molecular EntityJul 8, 2026
- FDA Approval: XELJANZ XR (TOFACITINIB) — Type 3 - New Dosage FormJul 8, 2026
- FDA Approval: RINVOQ (UPADACITINIB) — Type 1 - New Molecular EntityJul 8, 2026
- FDA Approval: XELJANZ (TOFACITINIB) — Type 3 - New Dosage FormJul 8, 2026
- FDA Approval: OLUMIANT (BARICITINIB) — Type 1 - New Molecular EntityJul 8, 2026
- FDA Approval: RINVOQ (UPADACITINIB) — Type 3 - New Dosage FormJul 8, 2026
- FDA Approval: EXDENSUR (DEPEMOKIMAB) — Type 1 - New Molecular EntityJun 13, 2026
- LCD L39427: MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid Arthritis — CGSCGS Administrators · Jun 5, 2026
- LCD L39481: MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid Arthritis — WPSWPS · Jun 5, 2026
- LCD L39467: MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid Arthritis — NoridianNoridian · Jun 5, 2026
- LCD L39469: MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid Arthritis — NoridianNoridian · Jun 5, 2026
Signal intelligence — Rheumatology × Novitas Solutions
Highest-risk CPT code
CPT 99214
Office visit, established patient, moderate complexity
View full CPT alert profileNovitas Solutions jurisdiction
JH, JL
Covers Arkansas, Colorado, Louisiana, Mississippi, New Mexico, Oklahoma, Texas, Delaware, District of Columbia, Maryland, New Jersey, Pennsylvania. Every rheumatology LCD revision, CMS transmittal, and Federal Register notice affecting these states is signal-scored and surfaced here daily.
View all 11 active alerts for Rheumatology under Novitas Solutions
Full alert text, action recommendations, effective date deadlines, MAC LCD links, and signal score rationale — updated daily.
About Novitas Solutions (Jurisdictions JH, JL)
Novitas Solutions is the Medicare Administrative Contractor responsible for processing Medicare Part A and Part B claims in Jurisdictions JH, JL, covering Arkansas, Colorado, Louisiana, Mississippi, New Mexico, Oklahoma, Texas, Delaware, District of Columbia, Maryland, New Jersey, Pennsylvania.Novitas Solutions issues Local Coverage Determinations (LCDs) that define coverage criteria, ICD-10-CM diagnosis code requirements, and CPT billing guidelines for Rheumatology procedures within its jurisdiction. CLV Intelligence monitors Novitas Solutions's LCD publication feed, provider bulletin archives, and CMS contractor-specific transmittals daily.
Rheumatology alerts in other MAC jurisdictions
Get weekly Rheumatology alerts for Novitas Solutions — free
No credit card required. Unsubscribe any time.